These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3088272

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Continuous oral contraception. Strategies for managing breakthrough bleeding.
    Freeman SB.
    Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
    [No Abstract] [Full Text] [Related]

  • 23. Effect of contraceptive steroids on creatine kinase activity in serum.
    Gupta U, Gupta RC.
    Clin Chem; 1982 Jun; 28(6):1402-3. PubMed ID: 7074957
    [No Abstract] [Full Text] [Related]

  • 24. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rationale for new oral contraceptive dosing.
    Williams JK.
    Int J Fertil Womens Med; 2004 Mar; 49(1):30-5. PubMed ID: 15038507
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN, Burkman R, Fisher AC, LaGuardia KD.
    Int J Fertil Womens Med; 2003 Mar; 48(4):163-72. PubMed ID: 13677549
    [Abstract] [Full Text] [Related]

  • 29. [Emergency contraception ].
    Amaliev G.
    Akush Ginekol (Sofiia); 2008 Mar; 47 Suppl 2():19-24. PubMed ID: 19504703
    [No Abstract] [Full Text] [Related]

  • 30. [Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations].
    Lachnit-Fixson U.
    Fortschr Med; 1984 Sep 06; 102(33):825-30. PubMed ID: 6383993
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun 06; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 37. [A clinical trial and use of triziston-R as a contraceptive agent].
    Masarliev A, Piperkov T, Grozdanov G.
    Akush Ginekol (Sofiia); 1989 Jun 06; 28(5):67-9. PubMed ID: 2697153
    [Abstract] [Full Text] [Related]

  • 38. [Endometrial interference of synthetic estrogens in fertility regulation.Is it necessary to interfere with the antiovulatory mechanism at the central nervous system level in order to obtain contraception?].
    Sojo Aranda QI, Rojas T, Cortés-Gallegos V.
    Ginecol Obstet Mex; 1997 Oct 06; 65():449-51. PubMed ID: 9432479
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.